JNJ

#16
Johnson & Johnson
235.07 USD
-1.48%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
234.51
236.50
Intervallo Annuale
146.12
251.71
Variazione giornaliera
-1.48%
Variazione Mensile
-3.50%
Variazione di 6 mesi
+22.21%
Variazione Annuale
+52.40%
Chiusura Precedente
238.60
Apertura
236.02
Bid
Ask
Minimo
234.51
High
236.50
Volume
1 871
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 566.49 B
  • Employee 141 K
  • Founded N/A
  • CEO Joaquin Duato
  • Website www.jnj.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BMHYD1
  • Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
18.82
Rapporto prezzo/fatturato
5.35
Dividendi per azione
5.14
Rendimento da dividendi %
2.48

Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.

Notizie